Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
220.00    20.00 (10.00%)
Bid:
215.00
Ask:
225.00
Spread: 10.00 (4.651%)
Market Cap: £127.76m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

Director Share Dealings

22 Nov 2017 14:50

RNS Number : 2617X
Focusrite PLC
22 November 2017
 



Focusrite Plc

 

("the Company" or "the Group")

 

Focusrite Plc FY17 Discretionary Director Bonus (FY17 Bonus)

Director Share Dealings

 

Focusrite Plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 22 November 2017 it issued 9,173 ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares") to Tim Carroll (CEO of the Company) and 27,466 Ordinary Shares to Jeremy Wilson (CFO of the Company) subject only to admission of such shares to trading on AIM ("Admission"). Accordingly, application has been made for 36,639 Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will occur on 28 November 2017. The new Ordinary Shares will rank pari-passu with the existing Ordinary Shares.

 

A proportion of these shares has been sold to settle the resultant income tax and national insurance liabilities. Consequently, Mr Carroll holds an aggregate of 9,173 Ordinary Shares, representing approximately 0.016 per cent of the Company's enlarged ordinary share capital and Mr Wilson holds an aggregate of 59,212 Ordinary Shares, representing approximately 0.102 per cent of the Company's enlarged ordinary share capital. Following Admission, the Company's issued share capital will comprise 58,111,639 Ordinary Shares, of which no Ordinary Shares are held in treasury. The total number of current voting rights in the Company following Admission will therefore be 58,111,639 Ordinary Shares.

 

The above figure of 58,111,639 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Number of Ordinary Shares

Director

Ordinary Shares issued at election of Director under the FY17 Bonus

Matching Ordinary Shares issued under the FY17 Bonus

Ordinary Shares sold to satisfy tax liabilities

Retained

Tim Carroll

4,586

4,586

4,423

4,750

Jeremy Wilson

13,733

13,733

13,241

14,225

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

 

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Tim Carroll

 

2

Reason for the notification

a)

Position/status

classified as PDMR of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

· 1. Shares acquired

· 2. Shares sold to satisfy tax liabilities

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Volumes Sold

1) 0.1p

2) 307p

9,173

-

-

4,423

d)

Aggregated information

- Aggregated volume 

- Price 

Aggregated price of shares acquired: £ 28,666.66

Aggregated price of shares sold: £ 13,578.61

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

London Stock Exchange - XLON

 

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Jeremy Wilson

2

Reason for the notification

a)

Position/status

classified as PDMR of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

· 1. Shares acquired

· 2. Shares sold to satisfy tax liabilities

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Volumes Sold

1) 0.1p

2) 307p

27,466

-

-

13,241

d)

Aggregated information

- Aggregated volume 

- Price 

Aggregated price of shares acquired: £ 85,831.25

Aggregated price of shares sold: £ 40,649.87

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

London Stock Exchange - XLON

 

 

-ends-

 

Enquiries:

 

Focusrite Plc:

David Bezem (Non-executive Director and Remuneration Committee Chairman)

+44 1494 462246

Mike Warriner (General Counsel)

+44 1494 462246

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBSBDBSBDBGRD
Date   Source Headline
30th Jun 202610:26 amRNSDirector/PDMR Shareholding
30th Jun 202610:16 amRNSTR-1
29th Jun 20267:00 amRNSFinal Results
27th May 20267:00 amRNSNotice of Results
5th May 20264:25 pmRNSTR-1
8th Apr 20263:56 pmRNSTR-1
19th Mar 20267:00 amRNSTrading Update: Trading in-line with expectations
2nd Mar 20267:00 amRNSBoard Changes
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:19 amRNSTransfer of shares to Trust
24th Dec 20259:19 amRNSTransfer of shares to Trust
18th Nov 202512:38 pmRNSDirector Share Dealings
4th Nov 20257:00 amRNSInterim Results
14th Oct 20257:00 amRNSNotice of Results
16th Sep 20257:00 amRNSTrading Update
7th May 20253:25 pmRNSTR-1
30th Apr 20253:41 pmRNSDividend Timetable Correction
29th Apr 20257:00 amRNSInterim Results
16th Apr 20252:38 pmRNSGrant of Share Options to PDMRs
11th Apr 20258:50 amRNSTR-1
8th Apr 20251:43 pmRNSTR-1
8th Apr 20257:00 amRNSTR-1
8th Apr 20257:00 amRNSTR-1
3rd Apr 20257:00 amRNSNotice of Interim Results
26th Mar 20253:16 pmRNSTR-1
20th Mar 20257:00 amRNSTrading Update
19th Mar 20258:13 amRNSTR-1
4th Mar 20252:46 pmRNSTR-1
31st Jan 202512:29 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement and Trading Update
11th Dec 20247:00 amRNSTR-1
5th Dec 20243:38 pmRNSDirector Share Dealings
5th Dec 20243:37 pmRNSGrant of Share Options to PDMRs
5th Dec 20247:00 amRNSTR1
27th Nov 20247:00 amRNSFinal Results for the Year Ended 31 Aug 2024
30th Oct 20247:00 amRNSNotice: Final Results, Change of Year End, Auditor
28th Aug 20247:00 amRNSTrading Statement
1st Aug 20247:00 amRNSTR-1
15th Jul 20244:17 pmRNSTR-1
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.